Lab Automation For In-Vitro Diagnostics Market Size (2024 - 2029)

Lab Automation For In-Vitro Diagnostics Market Analysis

The Lab Automation For In-Vitro Diagnostics Market size is estimated at USD 5.75 billion in 2024, and is expected to reach USD 7.80 billion by 2029, at a CAGR of 6.30% during the forecast period (2024-2029).

• Lab automation is the process of using specimen-processing equipment to conduct clinical research. This process is carried out to develop new technology to increase productivity and decrease time cycles. In vitro diagnostics are used in various settings, including laboratories, clinics, educational institutions, diagnostic centers, and private homes.
• Lab automation is becoming more common, particularly in developing IVD medical devices. Technology is assisting in increasing the productivity and throughput of in vitro diagnostics on an unprecedented scale. The market is expected to benefit from cognitive machine-learning capabilities and Big Data to supplement diagnostic test information and technologies to enable seamless connectivity between multiple instrument systems. Automation solutions are expected to be in high demand due to technological advancements.
• The increase in R&D activities in the pharmaceutical industries and the increase in demand for process automation for food safety are driving the growth of the market. The increase in the adoption of these systems due to workflow standardization and stringent regulatory control in the healthcare sector influences the growth of lab automation for the in vitro diagnostics market.
• Biopharma companies are under constant pressure to innovate and introduce new medications to the market. Research and development (R&D) and IT leaders are increasingly adopting advanced technologies, such as R&D data platforms, robotics, connected lab instruments, cloud-based SaaS applications, and AI and ML, to modernize their operations. This is driving the market’s growth.
• The 2024 IEEE International Conference on Robotics and Automation (ICRA 2024) symbolized robotics' integration into broader societal applications. ICRA serves as a global platform, uniting robotics researchers, students, and industry partners to delve into the latest advancements and emphasize how robotics and automation are pivotal in tackling worldwide challenges.
• Automating in vitro diagnostic devices allows the healthcare sector to drastically reduce potential errors, detect infection, diagnose medical conditions, prevent disease, and monitor drug therapies more accurately. For example, during pandemic outbreaks, robotics can be used to reduce infection exposure, distribute medications and food, assess vital signs, promote border control, and automate disinfection.
• Furthermore, incorporating AI and analytical tools into laboratory workflows expands the lab automation market's profitable opportunities. However, a lack of skilled laboratory professionals and the limited feasibility of technology integration in analytical labs will challenge and hinder market growth.
• Post-COVID-19, the importance of diagnostic capabilities was highlighted, leading to increased investments in IVD technologies and lab automation to enhance testing capacity and efficiency. Moreover, innovations in automatic technologies such as AI, robotics, and machine learning have enhanced diagnostic testing speed, making lab automation an attractive investment.

Lab Automation For In-Vitro Diagnostics Industry Segmentation

In vitro diagnostics (IVD) tests are medical devices that could be reagents, techniques, instruments, or a combination of these used in vitro to examine specimens such as blood, urine, or tissue to obtain a diagnosis from assays in a controlled environment. Diagnostic tests are usually conducted in laboratories, private or public, equipped with appropriate and sometimes expensive instrumentation and staffed with trained and qualified personnel to perform the tests.

The lab automation for in-vitro diagnostics market is segmented by equipment (automated plate handler, automated liquid handler, robotic arm, automated storage and retrieval system, and analyzer), end user (academic, laboratory, and other end users), and geography (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa). The report offers market sizes in value terms (USD) for all the above-mentioned segments.